Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Jul;79(7):642–645. doi: 10.1136/bjo.79.7.642

Continuous wave Nd:YAG laser photocoagulation in proliferative diabetic retinopathy.

U Menchini 1, P Lanzetta 1, F Soldano 1, E Ferrari 1, G Virgili 1
PMCID: PMC505189  PMID: 7662626

Abstract

AIMS--The therapeutic efficacy of the continuous wave (CW) Nd:YAG laser (working in the free running mode) was investigated in proliferative diabetic retinopathy (PDR) comparing it with a conventional laser source such as the krypton laser. METHODS--Twenty four eyes of 12 patients affected with bilateral PDR were included and divided in two groups. The right eyes were treated with a red krypton laser and the left eyes with a CW Nd:YAG laser. RESULTS--Three months after krypton photocoagulation 10 eyes showed a reduction or a complete regression of PDR and two eyes were unchanged. In the CW Nd:YAG laser group no eyes showed any regression of new vessels, in seven eyes the angiographic features were unchanged, and in five eyes they worsened. All the eyes of the second group underwent retreatment with the krypton laser after 3 or 6 months. After a mean follow up of 13 months all eyes in the krypton group showed a reduction or complete regression of PDR; in the retreated group 10 eyes improved and two were unchanged. CONCLUSIONS--The statistical analysis showed a highly significant difference (p = 0.001) between krypton and CW Nd:YAG laser which indicated the lack of efficacy of the latter in the treatment of PDR. In the krypton laser group no significant difference (p = 0.05) after the retreatment was found confirming the efficacy of this treatment.

Full text

PDF
642

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blankenship G. W. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison. Trans Am Ophthalmol Soc. 1986;84:967–1003. [PMC free article] [PubMed] [Google Scholar]
  2. Brancato R., Pratesi R., Leoni G., Trabucchi G., Vanni U. Histopathology of diode and argon laser lesions in rabbit retina. A comparative study. Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1504–1510. [PubMed] [Google Scholar]
  3. Fankhauser F., Kwasniewska S. A new universal laser apparatus for intra and extraocular irradiation tasks in the eye. Ophthalmic Surg. 1990 Apr;21(4):258–262. [PubMed] [Google Scholar]
  4. Fankhauser F., Van der Zypen E., Kwasniewska S., Loertscher H. The effect of thermal mode Nd:YAG laser radiation on vessels and ocular tissues. Experimental and clinical findings. Ophthalmology. 1985 Mar;92(3):419–426. doi: 10.1016/s0161-6420(85)34037-x. [DOI] [PubMed] [Google Scholar]
  5. GUERRY D., 3rd, HAM W. T., Jr, RUFFIN R. S., SCHMIDT F. H., TILLER C. O., WIESINGER H., WILLIAMS R. C. The transmission of light; through the ocular media of the rabbit eye. Am J Ophthalmol. 1956 Dec;42(6):907–910. [PubMed] [Google Scholar]
  6. L'Esperance F. A., Jr Clinical photocoagulation with the krypton laser. Arch Ophthalmol. 1972 Jun;87(6):693–700. doi: 10.1001/archopht.1972.01000020695016. [DOI] [PubMed] [Google Scholar]
  7. McHugh J. D., Marshall J., Ffytche T. J., Hamilton A. M., Raven A., Keeler C. R. Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye (Lond) 1989;3(Pt 5):516–527. doi: 10.1038/eye.1989.83. [DOI] [PubMed] [Google Scholar]
  8. Singerman L. J., Ferris F. L., 3rd, Mowery R. P., Brucker A. J., Murphy R. P., Lerner B. C., Mincey G. J. Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study. J Diabet Complications. 1988 Oct-Dec;2(4):189–196. doi: 10.1016/s0891-6632(88)80007-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES